Skip to main content
. 2019 Jun 2;10(14):3188–3196. doi: 10.7150/jca.30281

Table 1.

The characteristics of the 468 patients grouped by SII

Cases (number, %) SII (number) P value
468 (100) <479.72 ≥479.72
Gender 0.005*
Male 376 (80.3) 250 126
Female 92 (19.7) 75 17
Age (years) 0.484
≤60 247 (52.8) 168 79
>60 221 (47.2) 157 64
Smoking 0.546
Ever 209 (44.7) 142 67
Never 259 (55.3) 183 76
Drinking 0.309
Yes 286 (61.1) 189 97
No 182 (38.9) 136 46
Tumor length 0.261
≤3 70 (15) 53 17
>3 398 (85) 272 126
Tumor location 0.455
Upper 62 (13.2) 47 15
Middle 228 (48.7) 154 74
Lower 178 (38.0) 124 54
Differentiation 0.841
Well 123 (26.3) 88 35
Moderate 233 (49.8) 160 73
Poor 112 (23.9) 77 35
T stage 0.147
T1 46 (9.8) 38 8
T2 77 (16.5) 51 26
T3 274 (58.5) 191 83
T4 71 (15.2) 45 26
N stage 0.287
N0 238 (50.9) 166 72
N1 129 (27.6) 91 38
N2 74 (15.8) 46 28
N3 27 (5.8) 22 5
TNM stage 0.169
I 46 (9.8) 37 9
II 199 (42.5) 132 67
III 223 (47.6) 156 67
Operation time (min) 0.312
<200 200 (42.9) 144 56
≥200 268 (57.1) 181 87
Intraoperative blood loss (ml) 0.044*
<200 220 (47.0) 163 47
≥200 248 (53.0) 162 86

*P less than 0.05 is significant.

SII = systemic immune-inflammation index